image_dr-rüdiger-heicapell
9.3

Excellent

Qunoscore

Dr. Rüdiger Heicappell, MD, Professor of Urology

Asklepios Clinic Uckermark, Berlin, Germany

Practising since 1983

Prostate Cancer Treatment from€0

About Dr. Rüdiger Heicappell

Dr. Heicappell holds board certifications in Urology, Urologic Surgery, and Andrology for almost 30 years. He is specialized in therapy of urologic cancer as well as the treatment of erectile dysfunction, and male fertility. Moreover, Dr. Heicappell is a Professor of Urology at Freie Universität Berlin and currently serves as an academic teacher at the Pomeranian Medical University in Szczecin, Poland.

12,500

Treatments performed

41

Years of Experience

English, German

Languages Spoken

Education (3)

Career & Professional activities (7)

Qunoscore

9.3

Excellent

Qunoscore

Dr. Rüdiger Heicappell, MD, Professor of Urology has achieved 28 out of 35 points and is awarded with a Qunoscore of 9.3, Excellent.

Qunoscore allows you to compare hospitals and medical specialists from all over the world on a level playing field, and confidently choose the right professionals for your individual needs.

excellent
acceptable
insufficient

Qualification

Services offered

Value for money

Patient reviews

Clinic

Google Maps was not loaded due to privacy settings.

Please check your cookie preferences and reload the page.

Am Klinikum 1, 16303 Schwedt/Oder, Deutschland
Schwedt/Oder, Germany

Asklepios was founded in 1985 and is today Europe's largest privately family-owned clinic operator with around 150 health care facilities. Their entrepreneurial activities have always been aimed at providing future-oriented medicine for all patients entrusted to their care, based on the highest quality standards. They are represented in Germany with medical facilities in 14 federal states.

Good to know

Below find some of the frequently asked questions about your procedure and the trip.

Which Payment Methods Are Accepted?

How do I get a quote?

Where does prostate cancer commonly metastasize to?

Why is prostate cancer so common?